Regenerex Pharma (RGPX) Interest Expenses (2012 - 2025)
Regenerex Pharma (RGPX) reported Interest Expenses of $4000.0 for Q3 2025, down 98.5% year-over-year from $266157.0 in Q3 2024, and down 83.05% on a QoQ basis from $23596.0 in Q2 2025.
Regenerex Pharma (RGPX) has 10 years of Interest Expenses data on file, last reported at $4000.0 in Q3 2025.
- Quarterly Interest Expenses fell 98.5% year-over-year to $4000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $358305.0 (down 7.39% YoY) and the FY2025 annual result came in at $320047.0, up 296.89% from the prior year.
- Interest Expenses eased to $4000.0 in Q3 2025 per RGPX's latest filing, from $23596.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $303693.0 in Q1 2025 and bottomed at $4000.0 in Q3 2025.
- The 5-year median for Interest Expenses is $19153.5 (2023), against an average of $53213.5.
- The widest annual swing landed in 2024, when Interest Expenses soared 1244.16%; it then tumbled 98.5% in 2025.
- Tracing RGPX's Interest Expenses over 5 years: stood at $14548.0 in 2021, then rose by 18.51% to $17241.0 in 2022, then gained by 17.27% to $20219.0 in 2023, then jumped by 33.62% to $27016.0 in 2024, then slumped by 85.19% to $4000.0 in 2025.
- Per Business Quant, the three latest RGPX Interest Expenses figures stand at $4000.0 (Q3 2025), $23596.0 (Q2 2025), and $303693.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 23,596.00 |
| Jun 30, 2025 | 23,596.00 |
| Mar 31, 2025 | 303,693.00 |
| Mar 31, 2025 | 303,693.00 |
| Dec 31, 2024 | 27,016.00 |
| Dec 31, 2024 | 27,016.00 |
| Sep 30, 2024 | 266,157.00 |
| Sep 30, 2024 | 266,157.00 |
| Jun 30, 2024 | 22,333.00 |
| Jun 30, 2024 | 22,333.00 |
| Mar 31, 2024 | 78,195.00 |
| Mar 31, 2024 | 78,195.00 |
| Dec 31, 2023 | 20,219.00 |
| Dec 31, 2023 | 20,219.00 |
| Sep 30, 2023 | 19,801.00 |
| Sep 30, 2023 | 19,801.00 |
| Jun 30, 2023 | 18,506.00 |
| Jun 30, 2023 | 18,506.00 |
| Mar 31, 2023 | 65,898.00 |
| Mar 31, 2023 | 65,898.00 |
| Dec 31, 2022 | 17,241.00 |
| Dec 31, 2022 | 17,241.00 |
| Sep 30, 2022 | 16,607.00 |
| Sep 30, 2022 | 16,607.00 |
| Jun 30, 2022 | 15,518.00 |
| Jun 30, 2022 | 15,518.00 |
| Mar 31, 2022 | 14,933.00 |
| Mar 31, 2022 | 14,933.00 |
| Dec 31, 2021 | 14,548.00 |
| Dec 31, 2021 | 14,548.00 |
| Sep 30, 2021 | 16,840.00 |
| Sep 30, 2021 | 16,840.00 |
| Jun 30, 2021 | 12,742.00 |
| Jun 30, 2021 | 12,742.00 |
| Dec 31, 2020 | 11,203.00 |
| Dec 31, 2020 | 11,203.00 |
| Sep 30, 2020 | 10,808.00 |
| Sep 30, 2020 | 10,808.00 |
| Jun 30, 2020 | 9,324.00 |
| Jun 30, 2020 | 9,324.00 |
| Dec 31, 2019 | 8,028.00 |
| Dec 31, 2019 | 8,028.00 |
| Sep 30, 2019 | 6,762.00 |
| Sep 30, 2019 | 6,762.00 |
| Mar 31, 2019 | 30,022.00 |
| Mar 31, 2019 | 30,022.00 |
| Nov 30, 2014 | 870.00 |
| Nov 30, 2014 | 870.00 |
| Aug 31, 2014 | 1,087.00 |
| Aug 31, 2014 | 1,087.00 |
| May 31, 2014 | -713.00 |
| May 31, 2014 | -713.00 |
| Feb 28, 2014 | -886.00 |
| Feb 28, 2014 | -886.00 |
| Nov 30, 2013 | 1,469.00 |
| Nov 30, 2013 | 1,469.00 |
| Aug 31, 2013 | 1,097.00 |
| Aug 31, 2013 | 1,097.00 |
| May 31, 2013 | -885.00 |
| May 31, 2013 | -885.00 |
| Feb 28, 2013 | -927.00 |
| Feb 28, 2013 | -927.00 |
| Nov 30, 2012 | -958.00 |
| Nov 30, 2012 | -958.00 |
| Aug 31, 2012 | -946.00 |
| Aug 31, 2012 | -946.00 |
| May 31, 2012 | 8,758.00 |
| May 31, 2012 | 8,758.00 |